How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatmentGHANIMA, Waleed; GODEAU, Bertrand; CINES, Douglas B et al.Blood. 2012, Vol 120, Num 5, pp 960-969, issn 0006-4971, 10 p.Article

A Review of Second- line Chemotherapy and Prognostic Models for Disseminated Germ Cell TumorsVOSS, Martin H; FELDMAN, Darren R; BOSL, George J et al.Hematology/oncology clinics of North America. 2011, Vol 25, Num 3, issn 0889-8588, viii-ix, 557-576 [22 p.]Article

Extracorporeal photochemotherapy as second- or first-line therapy of acute GVHD?MERTIN, E; PAILLARD, C; ROCHETTE, E et al.Bone marrow transplantation (Basingstoke). 2010, Vol 45, Num 5, pp 963-965, issn 0268-3369, 3 p.Article

Metastatic melanoma: results of 'classical' second-line treatment with cytotoxic chemotherapiesPERRIN, Christophe; PRACHT, Marc; LEFEUVRE-PLESSE, Claudia et al.Journal of dermatological treatment. 2014, Vol 25, Num 5, pp 396-400, issn 0954-6634, 5 p.Article

Favorable outcome in infants with AML after intensive first- and second-line treatment: an AML-BFM study group reportCREUTZIG, U; ZIMMERMANN, M; STARY, J et al.Leukemia. 2012, Vol 26, Num 4, pp 654-661, issn 0887-6924, 8 p.Article

Current Management of Pyogenic Liver Abscess: Surgery is Now Second-Line TreatmentMEZHIR, James J; FONG, Yuman; JACKS, Lindsay M et al.Journal of the American College of Surgeons. 2010, Vol 210, Num 6, pp 975-983, issn 1072-7515, 9 p.Article

Early outcomes and the virological effect of delayed treatment switching to second-line therapy in an antiretroviral roll-out programme in South AfricaLEVISON, Julie H; ORRELL, Catherine; LOSINA, Elena et al.Antiviral therapy (London). 2011, Vol 16, Num 6, pp 853-861, issn 1359-6535, 9 p.Article

Front-Line Therapy With Second-Generation Tyrosine Kinase Inhibitors in Patients With Early Chronic Phase Chronic Myeloid Leukemia: What Is the Optimal Response?JABBOUR, Elias; KANTARJIAN, Hagop M; O'BRIEN, Susan et al.Journal of clinical oncology. 2011, Vol 29, Num 32, pp 4260-4265, issn 0732-183X, 6 p.Article

Second-line chemotherapy in patients with primary unknown cancerONO, Makiko; ANDO, Masashi; YONEMORI, Kan et al.Journal of cancer research and clinical oncology. 2011, Vol 137, Num 8, pp 1185-1191, issn 0171-5216, 7 p.Article

Esophageal Cancer: A Critical Evaluation of Systemic Second-Line TherapyROSINA THALLINGER, Christiane Maria; RADERER, Markus; HEJNA, Michael et al.Journal of clinical oncology. 2011, Vol 29, Num 35, pp 4709-4714, issn 0732-183X, 6 p.Article

Hypertension artérielle : traitement de deuxième ligne : D'autres monothérapies = Arterial hypertension and second choice therapiesLa Revue Prescrire. 2008, Vol 28, Num 293, pp 196-198, issn 0247-7750, 3 p.Article

The Importance of Patient Participation in Second-Line Chemotherapy Decisions : Perspectives of African-American PatientsPHIPPS, Etienne; MADISON, Nora; POLANSKY, Marcia et al.Journal of the National Medical Association. 2008, Vol 100, Num 12, pp 1434-1440, issn 0027-9684, 7 p.Article

Second-line chemotherapy in advanced biliary cancer: a systematic reviewLAMARCA, A; HUBNER, R. A; RYDER, W. David et al.Annals of oncology. 2014, Vol 25, Num 12, pp 2328-2338, issn 0923-7534, 11 p.Article

Evaluating Second-Line Treatment Options for Type 2 Diabetes: Focus on Secondary Effects of GLP-I Agonists and DPP-4 InhibitorsBOLAND, Cassie L; DEGEETER, Michelle; NUZUM, Donald S et al.The Annals of pharmacotherapy. 2013, Vol 47, Num 4, pp 490-505, issn 1060-0280, 16 p.Article

Sévélamer^(renagel°) hyperphosphorémie et dialyse péritonéale : En deuxième ligne = Sevelamer (Renagel°) Hyperphosphoremia and peritoneal dialysis : In second lineLa Revue Prescrire. 2007, Vol 27, Num 290, pp 891-891, issn 0247-7750, 1 p.Article

Complex Patterns of Protease Inhibitor Resistance among Antiretroviral Treatment-Experienced HIV-2 Patients from Senegal: Implications for Second-Line TherapyRAUGI, Dana N; SMITH, Robert A; DIA BADIANE, Ndeye Mery et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 6, pp 2751-2760, issn 0066-4804, 10 p.Article

Traitement de deuxième ligne du cancer bronchique non à petites cellules = Second line treatment of non-small-cell lung cancerQUOI, E; WESTEEL, V; PEROL, M et al.La Lettre du cancérologue (Boulogne). 2010, Vol 19, Num 9, pp 547-555, issn 1165-113X, 9 p.Article

Second-line chemotherapy versus supportive cancer treatment in advanced gastric cancer: a meta-analysisKIM, H. S; KIM, H. J; KIM, S. Y et al.Annals of oncology. 2013, Vol 24, Num 11, pp 2850-2854, issn 0923-7534, 5 p.Article

Second-line treatment in advanced pancreatic cancer: a comprehensive analysis of published clinical trialsRAHMA, O. E; DUFFY, A; LIEWEHR, D. J et al.Annals of oncology. 2013, Vol 24, Num 8, pp 1972-1979, issn 0923-7534, 8 p.Article

Long-Term Outcomes in the Second-Line Treatment of Chronic Myeloid Leukemia: A Review of Tyrosine Kinase InhibitorsJABBOUR, Elias; CORTES, Jorge; KANTARJIAN, Hagop et al.Cancer. 2011, Vol 117, Num 5, pp 897-906, issn 0008-543X, 10 p.Article

Chimiothérapie de deuxième ligne dans le cancer du pancréas métastatique: vers un nouveau standard ? = Second line chemotherapy for metastatic pancreatic cancer: a new standard?VAN LAETHEM, J. L; BACHET, J. B.La Lettre du cancérologue (Boulogne). 2010, Vol 19, Num 4, pp 251-253, issn 1165-113X, 3 p.Conference Paper

Efficacy of Rectal Misoprostol as Second-Line Therapy for the Treatment of Primary Postpartum HemorrhageBARUAH, Monideepa; COHN, Gabriel M.Journal of reproductive medicine. 2008, Vol 53, Num 3, pp 203-206, issn 0024-7758, 4 p.Article

Actualités sur la thérapie ciblée du cancer du sein : 14^e Conférence Européenne du Cancer (ECCO 2007), Barcelone, 23-27 septembre 2007LEVY TOLEDANO, Rachel.Oncologie (Paris). 2008, Vol 10, issn 1292-3818, 12 p., SUP2Serial Issue

New Developments in the Second-Line Treatment of Metastatic Colorectal Cancer: Potential Place in TherapyARNOLD, Dirk; STEIN, Alexander.Drugs (Basel). 2013, Vol 73, Num 9, pp 885-893, issn 0012-6667, 9 p.Article

Efficacy of Sitafloxacin-Based Rescue Therapy for Helicobacter pylori after Failures of First- and Second-Line TherapiesMATSUZAKI, Juntaro; SUZUKI, Hidekazu; NISHIZAWA, Toshihiro et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 3, pp 1643-1645, issn 0066-4804, 3 p.Article